Edward Healy
Physician Assistant · Elizabeth City, NCNPI 1710919055
Payments from drug & device makers
Across 229 payments — averaging $15.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$551
- Amgen$374
- Johnson & Johnson$333
- E.r. Squibb & Sons, L.L.C.$298
- Novartis$262
- Astellas Pharma US Inc$223
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,27293%
- Education$2517%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 34 | $551 |
| Amgen | 24 | $374 |
| Johnson & Johnson | 24 | $333 |
| E.r. Squibb & Sons, L.L.C. | 28 | $298 |
| Novartis | 17 | $262 |
| Astellas Pharma US Inc | 5 | $223 |
| Merck | 15 | $221 |
| Boston Scientific | 6 | $183 |
| Pfizer | 11 | $179 |
| Novo Nordisk | 9 | $137 |
| Sanofi-aventis U.S. LLC | 7 | $101 |
| Boehringer Ingelheim | 6 | $90 |
| Amarin Pharma, Inc. | 6 | $83 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 7 | $75 |
| Alnylam Pharmaceuticals Inc. | 4 | $66 |
| United Therapeutics Corporation | 7 | $55 |
| Kiniksa Pharmaceuticals, Ltd. | 3 | $52 |
| Actelion Pharmaceuticals US, Inc. | 3 | $47 |
| Kowa Pharmaceuticals America, Inc. | 3 | $41 |
| Philips North America LLC | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 2 | $32 |
| Bayer | 2 | $28 |
| Esperion Therapeutics, Inc. | 2 | $24 |
| Medtronic | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $15 |
How this compares
$3,523 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $46,342 |
| XareltoRivaroxaban | 26 | $17,818 |
| FarxigaDapagliflozin Propanediol | 20 | $17,645 |
| Amiodarone Hcl | 13 | $995 |
| Rosuvastatin Calcium | 33 | $673 |
| Ranolazine ErRanolazine | 12 | $563 |
| Amlodipine Besylate | 40 | $447 |
| ClopidogrelClopidogrel Bisulfate | 20 | $421 |
| Verapamil ErVerapamil Hcl | 11 | $420 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 27 | $370 |
| Metoprolol Succinate | 33 | $307 |
| Amlodipine Besylate-BenazeprilAmlodipine Besylate/Benazepril | 13 | $273 |
| Potassium Chloride | 16 | $247 |
| Atorvastatin Calcium | 33 | $222 |
| Carvedilol | 27 | $187 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $179 | $46,34258 claims |
| Johnson & JohnsonXarelto | $333 | $17,81826 claims |
| AstraZenecaFarxiga | $551 | $17,64520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Elizabeth City
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.